- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format. The electronic version of this UK Statutory Instrument has been contributed by Westlaw and is taken from the printed publication. Read more
These Regulations amend the Medicines Act 1968 so as to enable the implementation of certain Community obligations under two Council Directives Nos. 65/65/EEC and 75/319/EEC which relate to proprietary medicinal products.
The amendments relate to—
(a)requirements to hold licences by persons responsible for placing proprietary medicinal products on the market and by distributors of such products imported from outside the European Economic Community (regulations 2 and 3);
(b)the treatment of dossiers forwarded to the licensing authority under Article 9 of Council Directive 75/319/EEC as applications for product licences (regulation 4(2));
(c)refusal, suspension and revocation of licences (regulation 4(3) and (5); and
(d)duration of licences which are not in accordance with Community obligations (regulation 4(4)).
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: